Table of Contents
For decades, men with low testosterone had one main pharmaceutical option: testosterone replacement therapy. It works. It works well. But it comes with a significant trade-off: TRT shuts down your body's own testosterone production and suppresses sperm output, often severely. For men who want children — now or in the future — that's a serious problem.
Enclomiphene has changed the conversation. It's a selective estrogen receptor modulator (SERM) that tricks your brain into producing more of the hormones that tell your testes to make testosterone. Your body does the work itself. Fertility stays intact. And in January 2026, the British Society for Sexual Medicine published a formal position statement recognising enclomiphene as a "promising oral therapy" for secondary hypogonadism — a significant step toward mainstream medical acceptance.
What Is Enclomiphene?
Enclomiphene is the purified active isomer of clomiphene citrate (Clomid), a drug that has been used off-label for male infertility and low testosterone for years. Standard clomiphene is a mix of two isomers: enclomiphene (the anti-estrogenic component that raises testosterone) and zuclomiphene (a weak estrogen agonist responsible for most of clomiphene's side effects).
By isolating enclomiphene, you get the testosterone-boosting effect without the estrogenic side effects that made clomiphene problematic for many men — fewer mood swings, less risk of gynecomastia, no visual disturbances, and a half-life of 8-10 hours (versus zuclomiphene's roughly 30-day half-life, which caused unpredictable accumulation).
Enclomiphene is not FDA-approved as a standalone product. It is available through compounding pharmacies with a prescription, and several online TRT clinics now offer it as a first-line or adjunct treatment.
How Enclomiphene Works vs How TRT Works
The fundamental difference is directionality. They approach the same problem from opposite ends of the hormonal axis:
Enclomiphene works top-down. It blocks estrogen receptors in the hypothalamus and pituitary. Your brain, now "seeing" less estrogen, responds by increasing production of GnRH, which stimulates LH and FSH release. LH tells your testes to produce more testosterone. FSH maintains sperm production. Your entire HPG axis stays active — you're just removing the brake.
TRT works bottom-up. Exogenous testosterone is delivered directly (via injection, gel, or oral capsule). Your blood testosterone rises immediately. But your brain, detecting high testosterone and its downstream estrogen, suppresses LH and FSH. Your testes receive no signal to produce testosterone or sperm. Over weeks to months, testicular volume can decrease and sperm production can drop to near zero.
Why This Matters Beyond Fertility
Even if you have no plans for children, the axis suppression from TRT means you become dependent on external testosterone. Stop TRT, and your body may take months (or in some cases, require medical intervention) to restart its own production. Enclomiphene, by keeping the axis active, allows for easier discontinuation — your natural production hasn't been shut off, so it doesn't need to restart.
Clinical Data: How Much Does Enclomiphene Raise Testosterone?
The clinical evidence for enclomiphene is solid but more limited in scale than TRT's decades of research:
A Phase II trial published in The Journal of Sexual Medicine showed that enclomiphene produced significant increases in total testosterone within two weeks, while simultaneously elevating LH and FSH and preserving spermatogenesis. Multiple studies have demonstrated testosterone increases from baseline levels into the normal range (400-700 ng/dL) in men with secondary hypogonadism.
Typical results with enclomiphene (12.5-25 mg daily):
| Metric | Before Treatment | After 3-6 Months |
|---|---|---|
| Total testosterone | 150-300 ng/dL | 400-700 ng/dL typical |
| LH | Low-normal | Increases 2-3x |
| FSH | Low-normal | Increases (maintains spermatogenesis) |
| Sperm count | Normal | Maintained or improved |
| Estradiol | Variable | May increase (proportional to T) |
Important caveat: enclomiphene generally cannot achieve the testosterone levels that injectable TRT can. If your target is 800-1,100 ng/dL — common in optimisation protocols — enclomiphene alone may not get you there. It restores physiological production, which has a ceiling determined by your testicular capacity.
Head-to-Head Comparison
| Factor | Enclomiphene | TRT (Injectable) |
|---|---|---|
| Delivery | Oral capsule, daily | Injection, 1-3x weekly |
| Testosterone increase | Moderate (400-700 ng/dL typical) | High (600-1,100 ng/dL achievable) |
| Speed of effect | 2-4 weeks for labs; 4-8 weeks for symptoms | 1-2 weeks for labs; 2-4 weeks for symptoms |
| Fertility | Preserved or improved | Suppressed (often severely) |
| Testicular volume | Maintained | Decreases over time |
| HPG axis | Active (upregulated) | Suppressed |
| Discontinuation | Natural production continues; gradual return to baseline | Production shut down; restart can take months |
| Side effects | Generally mild (headache, occasional mood changes) | Erythrocytosis, acne, potential hair loss, sleep apnea |
| FDA status | Not FDA-approved; compounding pharmacy | FDA-approved (multiple formulations) |
| Cost | $30-$90/month (compounded) | $30-$200/month (clinic-dependent) |
| Insurance coverage | Rarely covered | Sometimes covered with diagnosis |
| Works for primary hypogonadism | No — testes can't respond | Yes |
The Fertility Question
This is the deciding factor for many men. The data is unambiguous:
TRT suppresses spermatogenesis. Exogenous testosterone suppresses LH and FSH to near-undetectable levels. Within 3-6 months, many men on TRT develop oligospermia (very low sperm count) or azoospermia (zero sperm). The American Urological Association explicitly warns against TRT for men desiring fertility. Recovery after stopping TRT can take 6-12 months and is not guaranteed — some men require medical intervention (HCG, clomiphene) to restart.
Enclomiphene preserves or improves spermatogenesis. Because enclomiphene increases FSH (the hormone that drives sperm production), it maintains and can even improve sperm parameters. The Ljubljana semaglutide-vs-TRT trial showed a 60% decrease in sperm concentration in the TRT group versus stable or improved concentrations in the non-TRT groups.
If You Want Children in the Next 5 Years
TRT is generally contraindicated if fertility is a near-term goal. Enclomiphene, HCG, or a combination is the standard recommendation from urologists and reproductive endocrinologists. If you're on TRT and decide you want children, discuss a transition plan with your provider — it typically involves stopping TRT and starting HCG and/or clomiphene/enclomiphene to restore spermatogenesis.
Who Should Choose What
Choose enclomiphene if:
- You want to preserve fertility (current or future)
- You have secondary hypogonadism (low T with low or normal LH — your testes can still produce if stimulated)
- You want to avoid injection dependence
- Your testosterone is borderline (200-350 ng/dL) and you want to try the least-invasive option first
- You're under 40 and unsure about lifelong TRT commitment
Choose TRT if:
- You have primary hypogonadism (elevated LH — your testes are failing and can't respond to stimulation)
- Fertility is not a concern (completed family, vasectomy, or no desire for biological children)
- You've tried enclomiphene and didn't achieve adequate testosterone levels or symptom relief
- You want maximum testosterone optimisation (800+ ng/dL targets)
- You prefer the faster, more predictable response of direct replacement
Consider both together if:
- You're on TRT and want to add fertility preservation (enclomiphene or HCG adjunct)
- You're transitioning from TRT to enclomiphene to restart natural production
Which Clinics Offer Enclomiphene
Not all online TRT clinics prescribe enclomiphene. The ones that do tend to position it as a first-line option for younger men or those with fertility concerns:
| Clinic | Enclomiphene Available | Pricing | Notes |
|---|---|---|---|
| Maximus Tribe | Yes — core offering | $149-$199/mo | Enclomiphene-first model; fertility-preserving by design |
| Hone Health | Yes — as alternative | $149/mo + meds | Offered alongside TRT; physician-guided choice |
| Hims | Yes — compounded enclomiphene | Varies | New entrant; also offers Kyzatrex oral TRT |
| Peter MD | Limited | $99-$150/mo | Primarily TRT-focused; enclomiphene on case-by-case basis |
The Bottom Line
Enclomiphene is not "TRT lite" — it's a fundamentally different approach to the same problem. For men with secondary hypogonadism who want to preserve fertility and HPG axis function, it's a clinically validated first-line option. For men with primary hypogonadism or those who need maximum testosterone optimisation, TRT remains the gold standard. Neither is universally better. The right choice depends on your biology, your life stage, and your goals.
Find a Clinic That Offers Both Options
Compare providers that prescribe enclomiphene, TRT, or both — matched to your priorities.
Take the 60-Second Quiz →Related reading: Maximus Review · TRT and Hair Loss · TRT Side Effects